Novel markers of coronary inflammation in patients with type 2 diabetes

J P M Andrews¹, M R Dweck^{2

3}

Affiliations

¹ British Heart Foundation, Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, EH16 4SB, UK. jack.andrews@ed.ac.uk.
² British Heart Foundation, Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, EH16 4SB, UK.
³ Icahn School of Medicine at Mount Sinai, Translational and Molecular Imaging Institute, New York, USA.

Editorial

J P M Andrews et al. J Nucl Cardiol. 2020 Aug.

. 2020 Aug;27(4):1365-1367.

doi: 10.1007/s12350-019-01866-x. Epub 2019 Sep 6.

J P M Andrews¹, M R Dweck^{2

3}

¹ British Heart Foundation, Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, EH16 4SB, UK. jack.andrews@ed.ac.uk.
² British Heart Foundation, Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, EH16 4SB, UK.
³ Icahn School of Medicine at Mount Sinai, Translational and Molecular Imaging Institute, New York, USA.

No abstract available

Comment on

Two-hour postload plasma glucose and pigment epithelium-derived factor levels are markers of coronary artery inflammation in type 2 diabetic patients.
Tahara N, Nitta Y, Bekki M, Tahara A, Maeda-Ogata S, Sugiyama Y, Honda A, Igata S, Nakamura T, Sun J, Kurata S, Fujimoto K, Abe T, Matsui T, Yamagishi SI, Fukumoto Y. Tahara N, et al. J Nucl Cardiol. 2020 Aug;27(4):1352-1364. doi: 10.1007/s12350-019-01842-5. Epub 2019 Aug 12. J Nucl Cardiol. 2020. PMID: 31407236

1. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32:2045–2051. doi: 10.1161/ATVBAHA.108.179705. - DOI - PMC - PubMed
1. Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377:1119–1131. doi: 10.1056/NEJMoa1707914. - DOI - PubMed
1. Mizoguchi M, Tahara N, Tahara A, Nitta Y, Kodama N, Oba T, et al. Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta. JACC Cardiovasc Imaging. 2011;4:1110–1118. doi: 10.1016/j.jcmg.2011.08.007. - DOI - PubMed
1. Dweck MR, Chow MW, Joshi NV, Williams MC, Jones C, Fletcher AM, et al. Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol. 2012;59:1539–1548. doi: 10.1016/j.jacc.2011.12.037. - DOI - PubMed
1. de Jong M, van der Worp HB, van der Graaf Y, Visseren FLJ, Westerink J. Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials. Cardiovasc Diabetol. 2017;16:134. doi: 10.1186/s12933-017-0617-4. - DOI - PMC - PubMed